Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer
Clinical trial NCT02980809 · UNKNOWN
Trial details
- NCT number
- NCT02980809
- Sponsor
- First Hospitals affiliated to the China PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2019-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.